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ABSTRACT
M
any fungi that cause invasive disease invade host
epithelial cells during mucosal and respiratory
infection, and subsequently invade endothelial cells
during hematogenous infection. Most fungi invade these
normally non-phagocytic host cells by inducing their own
uptake. Candida albicans hyphae interact with endothelial cells
in vitro by binding to N-cadherin on the endothelial cell
surface. This binding induces rearrangement of endothelial
cell microﬁlaments, which results in the endocytosis of the
organism. The capsule of Cryptococcus neoformans is composed
of glucuronoxylomannan, which binds speciﬁcally to brain
endothelial cells, and appears to mediate both adherence and
induction of endocytosis. The mechanisms by which other
fungal pathogens induce their own uptake are largely
unknown. Some angioinvasive fungi, such as Aspergillus
species and the Zygomycetes, invade endothelial cells from
the abluminal surface during the initiation of invasive
disease, and subsequently invade the luminal surface of
endothelial cells during hematogenous dissemination.
Invasion of normally non-phagocytic host cells has different
consequences, depending on the type of invading fungus.
Aspergillus fumigatus blocks apoptosis of pulmonary epithelial
cells, whereas Paracoccidioides brasiliensis induces apoptosis of
epithelial cells. This review summarizes the mechanisms by
which diverse fungal pathogens invade normally non-
phagocytic host cells and discusses gaps in our knowledge that
provide opportunities for future research.
Introduction
Pathogenic fungi interact with a variety of host cells during
the induction of disease. To cross tissue planes and cause
invasive disease, these organisms must invade normally non-
phagocytic host cells such as epithelial cells and endothelial
cells. The mechanisms by which bacteria invade these cells
have been a subject of intense investigation for many years
(reviewed in [1]). Since the 1990s researchers have been
investigating the processes by which pathogenic fungi invade
mammalian cells. This review summarizes the results of these
investigations (Table 1) and describes gaps in our knowledge
of fungal invasion. For the purpose of this article, we will use
the term invasion to indicate the penetration of all or part of a
fungus into a normally non-phagocytic host cell.
Candida Species
Epithelial cell invasion. Fungi of the genus Candida are part
of the normal human ﬂora and typically grow on mucosal
surfaces, such as those in the mouth and vagina. They can
cause a variety of different superﬁcial diseases, including
oropharyngeal, esophageal, vulvovaginal, and cutaneous
candidiasis. A common histopathologic ﬁnding in these
diseases is the presence of fungal cells within epithelial cells.
For example, intraepithelial fungi have been observed in
specimens from humans with oropharyngeal candidiasis [2–
5], vulvovaginal candidiasis [6], and cutaneous candidiasis [7].
It is postulated that the intracellular location of the
organisms protects them from the host immune response [6].
C. albicans is the predominant cause of virtually all types of
candidiasis. Thus, the interactions of this organism with
epithelial cells have been studied in the greatest detail. A key
virulence factor of C. albicans is its capacity to interconvert
between an ovoid-shaped blastospore and a ﬁlamentous
hypha [8,9]. Ultrastructural studies of specimens from
humans and experimental animals have suggested that C.
albicans hyphae are the invasive form of the organism, because
hyphae are found within epithelial cells, whereas blastospores
are generally found either on the epithelial cell surface or
between these cells [7,10].
Two different mechanisms of oral epithelial cell invasion
have been described. One mechanism is the production of
lytic enzymes, such as secreted aspartyl proteinases (SAPs), by
the organism. It has been proposed that these enzymes digest
the surface of the epithelial cell and thereby provide an
entrance into the cell. SAPs may be especially important for
the invasion of keratinized epithelial cells [10,11]. For
example, C. albicans blastospores induce depressions in the
surface of corneocytes in mice with cutaneous candidiasis, but
pepstatin A, an inhibitor of aspartyl proteinases, reduces the
formation of these depressions [10]. In fact, C. albicans mutants
containing disruptions of various SAP genes have a reduced
capacity to damage vaginal and oral epithelial cells in vitro
[12,13]. As epithelial cell invasion is likely a precursor of
epithelial cell damage, it is possible that the reduced damage
caused by the sapD/sapD mutants is due in part to decreased
epithelial cell invasion. Consistent with the in vitro results,
many of these sapD/sapD mutant strains have attenuated
Editor: Brendan P. Cormack, Johns Hopkins University School of Medicine, United
States of America
Citation: Filler SG, Sheppard DC (2006) Fungal invasion of normally non-
phagocytic host cells. PLoS Pathog 2(12): e129. doi:10.1371/journal.ppat.0020129
Copyright:  2006 Filler and Sheppard. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Abbreviations: GXM, glucuronoxylomannan; SAP, secreted aspartyl proteinase;
TNF-a, tumor necrosis factor a
Scott G. Filler is in the Division of Infectious Diseases at the Los Angeles Biomedical
Research Institute at Harbor-UCLA Medical Center, Torrance, California, United
States of America. Donald C. Sheppard is in the Department of Microbiology and
Immunology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
*To whom correspondence should be addressed. E-mail: sfiller@ucla.edu
PLoS Pathogens | www.plospathogens.org December 2006 | Volume 2 | Issue 12 | e129 1099virulence in the rat model of vaginal candidiasis [14]. It is also
possible that C. albicans SAPs play a role in tissue penetration
by facilitating the passage of the organism between host cells.
In this regard, the SAPs of C. albicans appear to be functionally
similar to the cysteine proteases of Porphyromonas gingivalis and
group A Streptococcus, which enable these bacteria to invade
and damage epithelial cells [15,16].
Another mechanism of candidal invasion of epithelial cells
is the induction of epithelial cell endocytosis. It has been
observed that C. albicans induces epithelial cells to produce
pseudopods that surround the organism and pull it into the
cell. The formation of these pseudopods is accompanied by
the accumulation of epithelial cell microﬁlaments around the
organism. These microﬁlaments are required for endocytosis
because disrupting them with cytochalasin D blocks the
uptake of C. albicans [17].
A variety of human epithelial cell lines are able to
endocytose C. albicans, including HeLa cells, HET1-A
esophageal cells, FaDu pharyngeal cells, and OKF6/TERT-2
oral epithelial cells [17–19]. However, the formation of
pseudopods by epithelial cells is difﬁcult to observe in vivo.
Thus, the relative contribution of endocytosis versus local
proteolytic digestion to the invasion of epithelial cells by C.
albicans in vivo remains to be determined. However, it is clear
that secreted proteases are not necessary for C. albicans to
induce its own endocytosis by epithelial cells in vitro, because
killed organisms are endocytosed as avidly as are live
organisms [17].
Although both yeast and hypha phase organisms can
induce endocytosis, hyphae are more efﬁcient at stimulating
this process. For example, an efg1D/efg1D mutant that does not
germinate on oral epithelial cells has a signiﬁcantly reduced
capacity to induce endocytosis [17]. The greater capacity of
hyphae to induce endocytosis compared with that of
blastospores suggests that hyphae express speciﬁc invasin-like
molecules on their surface that bind to one or more epithelial
cell receptors and induce endocytosis. However, the identities
of these candidal invasins and their epithelial receptors are
unknown at this time.
Two different signal transduction mutants of C. albicans
have been discovered to have a reduced capacity to induce
endocytosis by oral epithelial cells, even though they have
little or no defects in hypha formation. These mutants lack
either Tpk2, which is a catalytic subunit of protein kinase A,
or Cka2, which is a catalytic subunit of protein kinase CK2
[17,20]. However, it is not known whether Tpk1 and Cka2
govern the expression of the same or different epithelial cell
invasins. A C. albicans mutant that lacks the
glycosylphosphatidylinositol-linked protein Ecm33 also has a
reduced capacity to invade oral epithelial cells [21]. Ecm33 is
likely expressed on the fungal surface and is required for
normal cell wall assembly [22,23]. The heterologous
expression of ECM33 in Saccharomyces cerevisiae does not result
in enhanced endocytosis of this organism, suggesting that
Ecm33 itself does not mediate epithelial cell invasion. Also,
the ecm33D/ecm33D mutant has aberrant expression of at least
one other cell surface protein. Therefore, it is likely that the
invasion defect of the ecm33D/ecm33D mutant is due to
abnormal function and expression of one or more other cell
surface proteins.
Endothelial cell invasion. In susceptible patients, Candida
species can enter the bloodstream either by translocation
across the gastrointestinal mucosa or via an intravascular
catheter. To escape from the bloodstream and invade target
organs, these organisms must cross the endothelial cell lining
of the blood vessels. There are three general mechanisms by
which this process can occur. The ﬁrst mechanism is the
phagocytosis of the organism by a leukocyte, which then
Table 1. Summary of the Invasion Mechanisms of the Different Fungi and Their Host Cell Targets
Organism Target
Host Cell
Fungal Structure That
Induces Invasion
Host Cell
Receptor
Mechanism Microfilaments
Required
Microtubules
Required
Result of
Invasion
C. albicans Epithelial cells Unknown Unknown Zipper Yes Unknown Host cell damage,
fungal egress.
Endothelial cells Als3p expressed
by hyphae
N-cadherin and
other proteins
Zipper Yes Yes Host cell damage,
fungal egress.
Cr. neoformans Epithelial cells Capsule (GXM) Unknown Unknown Host cell damage,
fungal egress.
Brain endothelial
cells
Capsule (GXM) Unknown Membrane
ruffling
Yes Unknown Fungal egress (transcytosis),
minimal host cell damage.
A. fumigatus Epithelial cells Conidia Unknown Zipper Yes Yes Delayed fungal germination,
host cell damage, inhibition
of apoptosis.
Endothelial cells Hyphae Unknown Zipper Yes Unknown Host cell damage,
fungal egress.
R. oryzae Endothelial cells Hyphae Unknown Unknown Yes Unknown Host cell damage,
fungal egress.
S. schenckii Endothelial cells Yeast 90-kDa and
135-kDa
proteins
Unknown Unknown Unknown Intracellular persistence
of the organisms, no host
cell damage
H. capsulatum Epithelial cells Yeast Unknown Unknown Unknown Unknown Some organisms persist,
others are killed
P. brasiliensis Epithelial cells 30-kDa and 43-kDa
proteins expressed
by yeast
Unknown Unknown Yes Yes Intracellular persistence of the
organisms, induction of host cell
apoptosis
doi:10.1371/journal.ppat.0020129.t001
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vessel. Indeed, Candida species have been observed inside
leukocytes of patients with candidemia [24]. However, there
must be other mechanisms by which these organisms can
escape from the bloodstream, because disseminated
candidiasis can occur in patients with profound leucopenia.
A second mechanism is the passage of the organism between
the endothelial cells. Such a process would likely occur in
vascular beds of organs such as the kidney, where the
endothelial cell lining of the blood vessels is fenestrated. A
third mechanism is the endocytosis of the organism by
endothelial cells. This mechanism clearly occurs in vitro, and
has been the focus of multiple investigations [21,25–33].
Researchers have observed that C. albicans is endocytosed by
human umbilical vein endothelial cells [26–28], endothelial
cells in porcine vascular explants [25], and human brain
microvascular endothelial cells [32,34]. In most cases, the
endothelial cells produce pseudopods that engulf the
organism. Endocytosis of C. albicans requires intact
endothelial cell microﬁlaments and microtubules [27]; it is
also governed in part by the tyrosine phosphorylation of
endothelial cell proteins [31]. This process is passive on the
part of the organism because killed organisms are able to
induce endocytosis similarly to live organisms [27,29]. C.
albicans hyphae induce endocytosis by human umbilical vein
endothelial cells much more efﬁciently than do blastospores
[29].
The results of several studies have led to the development
of a model of how C. albicans hyphae induce their own
endocytosis by human umbilical vein endothelial cells in
vitro. In this model, C. albicans hyphae express an invasin-like
protein, Als3, which can bind to N-cadherin and other
proteins on the endothelial cell surface (Q. Phan, C. Myers, Y.
Fu, D. Sheppard, M. Yeaman, et al., unpublished data).
Binding to these surface proteins induces the
phosphorylation of at least two different endothelial cell
proteins, which in turn causes the rearrangement of the
endothelial cell microﬁlaments to produce pseudopods and
initiate endocytosis [19,30,31,35]. The N-terminal region of
Als3 contains the ligand-binding domain. This region is
predicted to share structural homology with the invasin
protein of Yersinia pseudotuberculsosis [35]. However, this
method of host cell invasion by C. albicans is reminiscent of
that induced by internalin A of Listeria monocytogenes, which
induces epithelial cell endocytosis by binding to E-cadherin
[36]. Many details of this model have yet to be elucidated,
including the identities of the endothelial cell surface
proteins other than N-cadherin that are bound by C. albicans,
and the identities of the proteins that are tyrosine
phosphorylated during the endocytosis of C. albicans. It also is
not yet known whether the binding of Als3 to N-cadherin
mediates endocytosis of C. albicans by endothelial cells in vivo.
It is clear that C. albicans interacts differently with
endothelial cells from different vascular beds. For example,
although human umbilical vein endothelial cells preferentially
endocytose hyphae, blastospores have been found to be avidly
endocytosed by porcine endothelial cells and human brain
microvascular endothelial cells in vitro [25,32,34]. In addition,
endothelial cells may act differently in vitro than in vivo. For
example, Saville et al. [9] investigated the role of hypha
formation in C. albicans virulence by constructing a strain of C.
albicans in which hypha formation was regulated by the
presence of tetracycline. They found that the fungal burden of
the kidneys, spleens, and brains of mice infected intravenously
with organisms that grew only as blastospores was at least as
high as that of mice infected with organisms that formed
hyphae. Thus, hypha formation does not appear to be
necessary for C. albicans to escape from the bloodstream and
invade target organs in immunocompetent mice.
Furthermore, some species of Candida, such as Candida glabrata,
are incapable of forming hyphae, yet are able to cause
hematogenously disseminated candidiasis in humans. How
blastospores of Candida species are able cross the endothelial
cell lining of the vasculature is currently unknown.
Cryptococcus neoformans
Epithelial cell invasion. Cryptococcosis develops when a
susceptible host inhales Cr. neoformans. Once inside the lungs,
the organism penetrates the alveolus. Cr. neoformans adheres
to and is internalized by pulmonary epithelial cells in vitro
[37–39]. However, relatively little is known about its
mechanisms of epithelial cell invasion. A key virulence factor
of Cr. neoformans is the presence of a capsule, which is
composed of glucuronoxylomannan (GXM). This capsule
inhibits phagocytosis of Cr. neoformans by leukocytes.
Interestingly, type II pneumocytes apparently have a receptor
for GXM. These cells can internalize both unencapsulated
and encapsulated strains of Cr. neoformans, as well as purﬁed
GXM [38,39]. Furthermore, adherence of encapsulated
organisms to these epithelial cells can be inhibited by GXM.
However, the identity of the GXM receptor on pulmonary
epithelial cells remains to be determined.
Endothelial cell invasion. To cause meningitis, Cr.
neoformans must enter the bloodstream, and then cross the
microvascular endothelial cells that form the blood–brain
barrier. Two different studies have found Cr. neoformans cells
inside of brain endothelial cells in mice infected
intravenously with live organisms [40,41]. Thus, Cr. neoformans
can cross the endothelial cell lining of the cerebral blood
vessels by a transcellular mechanism. The interaction of Cr.
neoformans with endothelial cells has also been analyzed in
vitro. Both encapsulated and unencapsulated organisms are
able to induce their own endocytosis by brain microvascular
endothelial cells [41,42]. The organisms induce membrane
rufﬂing and projection of microvilli that surround the
organisms and pull them into the cell. This membrane
rufﬂing is induced by rearrangement of the endothelial cell
microﬁlaments; this rearrangement is likely stimulated by the
dephosphorylation of coﬁlin [42].
Once Cr. neoformans is internalized by a brain microvascular
endothelial cell, it can exit through the abluminal surface of
the cell. Thus, these in vitro ﬁndings support the conclusion
of the above animal studies that Cr. neoformans can cross brain
microvascular endothelial cells by the process of transcytosis.
Interestingly, although there is a suggestion that the tight
junctions between the brain microvascular endothelial cells
are weakened by the transcytosis of Cr. neoformans, there is no
reduction in transendothelial cell electrical resistance.
Therefore, the transcytosis process appears to cause minimal
endothelial cell damage. [42].
Although both encapsulated and unencapsulated strains
can transcytose across brain microvascular endothelial cells,
studies with isogenic mutants suggest that the presence of a
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as well as the rate of transcytosis [42,43]. The presence of a
capsule has a completely different effect on the interactions
of Cr. neoformans with human umbilical vein endothelial cells.
Ibrahim et al. [44] found that these endothelial cells can
endocytose unencapsulated Cr. neoformans, but not
encapsulated strains. Moreover, efﬁcient endocytosis of the
uncapsulated strain of Cr. neoformans by human umbilical vein
endothelial cells requires the presence of a heat-labile serum
factor. Therefore, it is likely that the tropism of Cr. neoformans
for the brain is due in part to the unique ability of brain
endothelial cells to bind and endocytose encapsulated
organisms. Strains of Escherichia coli that cause meningitis in
neonates also have tropism for the central nervous system. It
has been found that microvascular brain endothelial cells
express a protein called gp96 that is bound by the E. coli
OmpA. Endothelial cells from other vascular beds do not
express this protein, and thus are invaded poorly by E. coli in
vitro [45]. Based on these results, it seems likely that the Cr.
neoformans capsule is bound by a receptor that is expressed
most highly by brain endothelial cells.
Coenjaerts et al. [46] used serial analysis of gene expression
to identify Cr. neoformans genes that were up-regulated in
response to endocytosis by human umbilical vein endothelial
cells. They determined that SKN7, which encodes the effector
element of a two-component signaling system, was up-
regulated by 4.5-fold in Cr. neoformans cells that were
endocytosed by endothelial cells. Interestingly, a skn7D
deletion mutant appeared to be killed by the umbilical vein
endothelial cells after it had been endocytosed. However,
although this strain was hypersensitive to hydrogen peroxide,
it was not more susceptible to killing by either neutrophils or
peripheral blood mononuclear cells. The skn7D deletion
mutant did have attenuated virulence in mice inoculated
intravenously, though. These results suggest that endothelial
cells from systemic blood vessels may actually be able to kill
Cr. neoformans. The role of Skn7 in governing the response of
Cr. neoformans to brain endothelial cells is unknown at this
time.
Aspergillus fumigatus
Invasion of epithelial cells. Invasive aspergillosis is initiated
by inhalation of conidia, which, by virtue of their small size,
are deposited in the alveoli. These conidia subsequently
invade the epithelial cell lining of the alveoli (Figure 1). A.
fumigatus causes the majority of cases of invasive aspergillosis
[47], and the interactions of this organism with host cells have
therefore been studied in greater detail than other Aspergillus
species. A. fumigatus conidia and hyphae have been found to
induce their own endocytosis by type II pneumocytes [48–50].
Conidia can also be endocytosed by tracheal epithelial cells,
but at a lower efﬁciency than that of type II pneumocytes [49].
Contact with A. fumigatus conidia induces type II pneumocytes
to produce pseudopods that engulf the organism [49]. The
formation of these pseudopods requires intact host cell
microﬁlaments and microtubules. Once the conidia are
internalized by type II pneumocytes, they trafﬁc to late
endosomes/lysosomes, as indicated by the presence of
lysosomal-associated protein 1 and cathepsin D in these
doi:10.1371/journal.ppat.0020129.g001
Figure 1. Model of Aspergillus fumigatus Interactions with Pulmonary Epithelial Cells and Vascular Endothelial Cells during Angioinvasion and
Dissemination
Invasive aspergillosis occurs via the following steps: infection is initiated by the inhalation of small numbers of airborne conidia (A), which adhere to
pulmonary epithelial cells (B), and are rapidly endocytosed (C). Within the epithelial cells, the conidia germinate to form hyphae (D), which grow by
apical extension and escape from the epithelial cells (E). Next, emergent hyphae penetrate the abluminal surface of endothelial cells (F) and induce
endothelial cell damage (G). Hyphal fragments disseminate hematogenously (H) and adhere to the luminal endothelial cell surface (I) before invading
these cells (J). Luminal invasion results in endothelial cell damage (K) and extravascular invasion of deep organs (L). Steps (A–E) occur in the pulmonary
alveoli, (F–H) in the pulmonary blood vessels, and (I–L) in the systemic blood vessels.
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conidia are acidic [51].
The endocytosis of A. fumigatus conidia by type II
pneumocytes has signiﬁcant effects on both the organism and
the host cell. Germination of the endocytosed conidia is
signiﬁcantly delayed compared with conidia that are grown in
the absence of pneumocytes. However, many of the conidia
eventually germinate, and the resultant hyphae can escape
from the endosome and penetrate the plasma membrane of
the pneumocyte. Remarkably, this process causes virtually no
detectable damage to the host cell [51]. In fact, A. fumigatus
conidia have been found to suppress apoptosis of type II
pneumocytes induced by either tumor necrosis factor a
(TNF-a) or staurosporine. Inhibition of apoptosis is an active
process on the part of the conidia because killed conidia do
not inhibit pneumocyte apoptosis, even though they are
endocytosed [52]. The mechanism by which conidia inhibit
pneumocyte apoptosis is currently unknown. However, it is
likely that ability of A. fumigatus to use viable type II
pneumocytes as a sanctuary contributes to the virulence of
this organism.
Invasion of endothelial cells. Invasion of the blood vessels is
a key feature of invasive aspergillosis [53,54]. This
angioinvasion contributes to tissue necrosis at the foci of
infection and reduces the penetration of leukocytes and
antifungal drugs to these sites. There are two types of
angioinvasion that occur during invasive aspergillosis (Figure
1); the ﬁrst type occurs in the lungs. After A. fumigatus hyphae
have penetrated the pulmonary epithelium, they invade the
vasculature by passing from the abluminal to the luminal
surface of the pulmonary endothelial cells. This process
results in disruption of the endothelial cell monolayer at the
focus of angioinvasion and intravascular thrombosis. This
type of angioinvasion is most common. The second type of
angioinvasion occurs in profoundly immunocompromised
patients. In these patients, hyphae that have entered the
bloodstream break off, and the resultant hyphal fragments
disseminate hematogenously throughout the body. For these
hyphal fragments to invade the target organs, they must
penetrate the luminal surface of the vascular endothelial
cells.
Endothelial cells are polarized. For example, unstimulated
endothelial cells constitutively secrete 3-fold more von
Willebrand factor via their abluminal surface than via their
luminal surface. When these cells are stimulated with TNF-a,
virtually all of the von Willebrand factor is secreted
luminally [55]. Also, endothelial cells exhibit a greater
increase in permeability when TNF-a is applied to their
luminal surface compared with their abluminal surface [56].
Therefore, it is likely that endothelial cells respond
differently to A. fumigatus when it invades their abluminal
surface than when it invades their luminal surface.
To date, all of the published studies of the interactions of A.
fumigatus with endothelial cells have focused on luminal
infection. A. fumigatus conidia and hyphae can invade the
luminal surface of endothelial cells by inducing their own
endocytosis in vitro [49,57,58]. The signiﬁcance of conidial
invasion of endothelial cells is uncertain because it is highly
probable that the organism has formed hyphae by the time it
invades endothelial cells in vivo [53]. Hyphae are endocytosed
by the luminal surface of human umbilical vein endothelial
cells more slowly than are conidia. Endocytosis of hyphae
causes endothelial cell damage as well as up-regulation of
endothelial cell–tissue factor expression [57]. It is likely that
the expression tissue factor contributes to the vascular
thrombosis at sites of A. fumigatus angioinvasion.
Recently, we compared the response of endothelial cells to
A. fumigatus hyphae when they were infected via their luminal
surface with the response of cells to hyphae infected via their
abluminal surface in vitro. The hyphae invaded both surfaces
of the endothelial cells. Luminal invasion caused greater
endothelial cell damage, yet induced less expression of mRNA
for E-selectin, TNF-a, interleukin-8, and tissue factor (Y.
Kamai, A. Lossinsky, D. Sheppard, and S. Filler, unpublished
data). These results suggest that the pathogenesis of
angioinvasion during locally invasive aspergillosis may be
different from that of hematogenously disseminated
aspergillosis. The A. fumigatus invasins and endothelial cell
receptors that mediate invasion of the luminal versus
abluminal surface of endothelial cells remain to be identiﬁed.
Other Fungi
Zygomycetes. Zygomycosis, also known as mucormycosis, is
caused by fungi of the class Zygomycetes. This disease is
usually initiated by inhalation, and the fungus is believed to
penetrate the epithelial cell lining of the nasopharynx or
pulmonary alveoli [59]. Like invasive aspergillosis,
zygomycosis is characterized by angioinvasion from the
abluminal to the luminal surface of the blood vessels [60]. The
Zygomycetes occasionally cause hematogenously
disseminated disease. Despite the prominence of
angioinvasion in the pathogenesis of zygomycosis, there has
only been one report of the interactions of a Zygomycete with
endothelial cells. Ibrahim et al. [61] examined the endothelial
cell interactions of Rhizopus oryzae, the most common cause of
zygomycosis. They found that both live and killed R. oryzae
hyphae were endocytosed by human umbilical vein
endothelial cells. The endocytosis of live hyphae caused
signiﬁcant endothelial cell damage. Interestingly, killed
hyphae induced a similar extent of endothelial cell damage,
suggesting that a factor associated with the fungal cell wall is
toxic to these cells. Damage to endothelial cells results in
exposure of vascular smooth muscle cells, which can release
large quantities of tissue factor and cause intravascular
thrombosis [62]. Thus, induction of endothelial cell damage
during angioinvasion may contribute to thrombosis and
tissue infarction, which are characteristic of mucormycosis.
Sporothrix schenckii. Sporotrichosis is caused by S. schenckii
[63] and primarily involves the skin and lymphatic channels,
but hematogenous dissemination may also occur [63,64].
During hematogenous dissemination, it is likely that the
organism penetrates the endothelial cell lining of the
vasculature to invade the deep tissues. S. schenckii has been
found to invade human umbilical vein endothelial cells in
vitro by inducing its own endocytosis [65]. Unlike other
pathogens, endothelial cell invasion does not result in
detectable endothelial cell damage. Binding of S. schenckii to
endothelial cells is enhanced when the host cells are
stimulated with interleukin-1b, indicating that this organism
binds to an inducible receptor on the endothelial cell surface
[65]. This situation is similar to that which has been seen with
Streptococcus pneumoniae, which binds to the platelet-activating
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of activated endothelial cells [66].
Histoplasma capsulatum. Pulmonary or disseminated
histoplasmosis is initiated by the inhalation of H. capsulatum.
After initial infection, the organism can persist in the host for
years and reactivate when immunity wanes [67]. It is possible
that H. capsulatum survives for long periods of time in more
than one type of host cell. For example, the organism is
known to persist in macrophages in vivo and in vitro [68]. H.
capsulatum yeast can also survive after being endocytosed by
hamster tracheal epithelial cells in vitro [69,70]. Whether this
organism persists in epithelial cells in vivo is currently
unknown. Some of the yeast that are endocytosed by
epithelial cells contain a-(1,3)-glucan in their cell walls,
whereas others do not. The yeast with a-(1,3)-glucan appear
to be killed by the epithelial cells. It remains to be determined
whether this killing is mediated by epithelial cell–derived
reactive oxygen intermediates and/or defensins. Other yeast
spontaneously lose the ability to produce a-(1,3)-glucan and
are able to persist in the epithelial cells; these persistent
organisms may serve as a reservoir for latent infection [69,70].
Paracoccidioides brasiliensis. Infection with P. brasiliensis
usually begins following inhalation of conidia. These conidia
transform into yeast, which cause both pulmonary and
disseminated disease [71]. The yeast have been visualized
within the alveolar walls and macrophages during
experimental pulmonary infection in mice [72]. In vitro
investigations of the interactions of P. brasiliensis with
normally non-phagocytic host cells have mainly used African
green monkey kidney cells (Vero cells) [73–75]. However,
there is one report of the interactions of this organism with a
type II pneumocyte cell line [74]: P. brasiliensis adheres to and
then is endocytosed by epithelial cells. Adherence is mediated
in part by two different P. brasiliensis proteins with molecular
masses of 30 and 43 kDa [75]. The endocytosis of this fungus
requires intact epithelial cell microﬁlaments and
microtubules, and triggers host cell apoptosis [74]. The
identities of the P. brasiliensis adhesins and the host receptors
to which they bind are currently unknown.
Summary
Most pathogenic fungi invade normally non-phagocytic
host cells by inducing their own endocytosis. Although the
invasion of these host cells is likely central to pathogenesis of
disease, there are large gaps in our knowledge about whether
invasion is induced by a membrane-rufﬂing or zipper
mechanism. Furthermore, for those fungi that induce their
own endocytosis by a zipper mechanism, there is a paucity of
knowledge about the fungal surface proteins that induce
invasion, the host cell receptor to which these endocytosing-
inducing proteins bind, and the host cell signal transduction
mechanisms that govern fungal invasion. However, the tools
to efﬁciently ﬁll these gaps in knowledge have already been
developed within the last decade during the study of host cell
invasion by viral, bacterial, and protozoal pathogens.
Therefore it is highly likely that mechanisms of fungal
invasion will be more clearly elucidated in the near future. &
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